COPEDOL: A two-year observational study in pretreated HIV-1-infected patients switching to a dolutegravir-based regimen

Autor: Landman, R., Marcelin, A.G., Bennani, M., Philippe, C. *, Kousignian, P., Finkielsztejn, L., Roustand, L., Nachbaur, G., Pourcher, V.
Zdroj: In Infectious Diseases Now March 2022 52(2):93-100
Databáze: ScienceDirect